Clinical trial NCT02715336 - References

Pregnancy — Efficacy and Safety of Medication Used to Stimulate Ovulation

Citation(s)

•   Acevedo B, Gomez-Palomares JL, Ricciarelli E, Hernández ER
  Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates. Fertil Steril. 2006 Dec;86(6):1682-7. Epub 2006 Oct 30.
•   Blazquez A, Guillén JJ, Colomé C, Coll O, Vassena R, Vernaeve V
  Empty follicle syndrome prevalence and management in oocyte donors. Hum Reprod. 2014 Oct 10;29(10):2221-7. doi: 10.1093/humrep/deu203. Epub 2014 Aug 1.
•   Bodri D, Guillén JJ, Trullenque M, Schwenn K, Esteve C, Coll O
  Early ovarian hyperstimulation syndrome is completely prevented by gonadotropin releasing-hormone agonist triggering in high-risk oocyte donor cycles: a prospective, luteal-phase follow-up study. Fertil Steril. 2010 May 1;93(7):2418-20. doi: 10.1016/j.fertnstert.2009.08.036. Epub 2009 Oct 2.
•   Broekmans FJ, Verweij PJ, Eijkemans MJ, Mannaerts BM, Witjes H
  Prognostic models for high and low ovarian responses in controlled ovarian stimulation using a GnRH antagonist protocol. Hum Reprod. 2014 Aug;29(8):1688-97. doi: 10.1093/humrep/deu090. Epub 2014 Jun 5.
•   Datta AK, Eapen A, Birch H, Kurinchi-Selvan A, Lockwood G
  Retrospective comparison of GnRH agonist trigger with HCG trigger in GnRH antagonist cycles in anticipated high-responders. Reprod Biomed Online. 2014 Nov;29(5):552-8. doi: 10.1016/j.rbmo.2014.08.006. Epub 2014 Aug 28.
•   Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C
  The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil Steril. 2008 Jan;89(1):84-91. Epub 2007 Apr 26.
•   Fauser BC, de Jong D, Olivennes F, Wramsby H, Tay C, Itskovitz-Eldor J, van Hooren HG
  Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. J Clin Endocrinol Metab. 2002 Feb;87(2):709-15.
•   Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L; ESHRE working group on Poor Ovarian Response Definition
  ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011 Jul;26(7):1616-24. doi: 10.1093/humrep/der092. Epub 2011 Apr 19.
•   Garcia JE, Jones GS, Acosta AA, Wright G Jr
  Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: phase I, 1981. Fertil Steril. 1983 Feb;39(2):167-73.
•   Gonen Y, Balakier H, Powell W, Casper RF
  Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization. J Clin Endocrinol Metab. 1990 Oct;71(4):918-22.
•   Griffin D, Benadiva C, Kummer N, Budinetz T, Nulsen J, Engmann L
  Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders. Fertil Steril. 2012 Jun;97(6):1316-20. doi: 10.1016/j.fertnstert.2012.03.015. Epub 2012 Apr 3.
•   Griffin D, Feinn R, Engmann L, Nulsen J, Budinetz T, Benadiva C
  Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates. Fertil Steril. 2014 Aug;102(2):405-9. doi: 10.1016/j.fertnstert.2014.04.028. Epub 2014 May 17.
•   Haas J, Zilberberg E, Dar S, Kedem A, Machtinger R, Orvieto R
  Co-administration of GnRH-agonist and hCG for final oocyte maturation (double trigger) in patients with low number of oocytes retrieved per number of preovulatory follicles--a preliminary report. J Ovarian Res. 2014 Aug 2;7:77. doi: 10.1186/1757-2215-7-77.
•   Huber M, Hadziosmanovic N, Berglund L, Holte J
  Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-releasing hormone-agonist protocol: suggestions for a new principle to solve an old problem. Fertil Steril. 2013 Nov;100(5):1270-6. doi: 10.1016/j.fertnstert.2013.06.049. Epub 2013 Aug 6.
•   Humaidan P, Bredkjaer HE, Bungum L, Bungum M, Grøndahl ML, Westergaard L, Andersen CY
  GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Hum Reprod. 2005 May;20(5):1213-20. Epub 2005 Mar 10.
•   Humaidan P, Kol S, Papanikolaou EG; Copenhagen GnRH Agonist Triggering Workshop Group
  GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Hum Reprod Update. 2011 Jul-Aug;17(4):510-24. doi: 10.1093/humupd/dmr008. Epub 2011 Mar 30. Review.
•   Humaidan P, Polyzos NP, Alsbjerg B, Erb K, Mikkelsen AL, Elbaek HO, Papanikolaou EG, Andersen CY
  GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients. Hum Reprod. 2013 Sep;28(9):2511-21. doi: 10.1093/humrep/det249. Epub 2013 Jun 9.
•   Humaidan P, Polyzos NP
  Human chorionic gonadotropin vs. gonadotropin-releasing hormone agonist trigger in assisted reproductive technology--"the king is dead, long live the king!". Fertil Steril. 2014 Aug;102(2):339-41. doi: 10.1016/j.fertnstert.2014.04.047. Epub 2014 Jun 4.
•   Klein JU, Sauer MV
  Ethics in egg donation: past, present, and future. Semin Reprod Med. 2010 Jul;28(4):322-8. doi: 10.1055/s-0030-1255180. Epub 2010 Aug 3. Review.
•   Kolibianakis EM, Schultze-Mosgau A, Schroer A, van Steirteghem A, Devroey P, Diedrich K, Griesinger G
  A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Hum Reprod. 2005 Oct;20(10):2887-92. Epub 2005 Jun 24.
•   Lainas TG, Sfontouris IA, Papanikolaou EG, Zorzovilis JZ, Petsas GK, Lainas GT, Kolibianakis EM
  Flexible GnRH antagonist versus flare-up GnRH agonist protocol in poor responders treated by IVF: a randomized controlled trial. Hum Reprod. 2008 Jun;23(6):1355-8. doi: 10.1093/humrep/den107. Epub 2008 Apr 10.
•   Lin MH, Wu FS, Lee RK, Li SH, Lin SY, Hwu YM
  Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles. Fertil Steril. 2013 Nov;100(5):1296-302. doi: 10.1016/j.fertnstert.2013.07.1976. Epub 2013 Aug 28.
•   Melo M, Busso CE, Bellver J, Alama P, Garrido N, Meseguer M, Pellicer A, Remohí J
  GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study. Reprod Biomed Online. 2009 Oct;19(4):486-92.
•   Nastri CO, Teixeira DM, Moroni RM, Leitão VM, Martins WP
  Ovarian hyperstimulation syndrome: pathophysiology, staging, prediction and prevention. Ultrasound Obstet Gynecol. 2015 Apr;45(4):377-93. doi: 10.1002/uog.14684. Epub 2015 Mar 1. Review.
•   Papanikolaou EG, Humaidan P, Polyzos NP, Tarlatzis B
  Identification of the high-risk patient for ovarian hyperstimulation syndrome. Semin Reprod Med. 2010 Nov;28(6):458-62. doi: 10.1055/s-0030-1265671. Epub 2010 Nov 16. Review.
•   Prapas Y, Panagiotidis I, Kalogiannidis I, Gjata E, Papatheodorou A, Prapa S, Kasapi L, Goudakou M, Prapas N
  Double GnRH-antagonist dose before HCG administration may prevent OHSS in oocyte-donor cycles: a pilot study. Reprod Biomed Online. 2010 Aug;21(2):159-65. doi: 10.1016/j.rbmo.2010.04.030. Epub 2010 Jun 2.
•   Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004 Jan;81(1):19-25.
•   Seyhan A, Ata B, Polat M, Son WY, Yarali H, Dahan MH
  Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG. Hum Reprod. 2013 Sep;28(9):2522-8. doi: 10.1093/humrep/det124. Epub 2013 Apr 30.
•   Sills ES, Alper MM, Walsh AP
  Ovarian reserve screening in infertility: practical applications and theoretical directions for research. Eur J Obstet Gynecol Reprod Biol. 2009 Sep;146(1):30-6. doi: 10.1016/j.ejogrb.2009.05.008. Epub 2009 May 31. Review.
•   Sunkara SK, Coomarasamy A, Faris R, Braude P, Khalaf Y
  Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial. Fertil Steril. 2014 Jan;101(1):147-53. doi: 10.1016/j.fertnstert.2013.09.035. Epub 2013 Nov 1. Erratum in: Fertil Steril. 2014 Jun;101(6):1791.
•   Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J
  Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update. 2003 Jan-Feb;9(1):61-76. Review.
•   Tremellen K, Savulescu J
  Ovarian reserve screening: a scientific and ethical analysis. Hum Reprod. 2014 Dec;29(12):2606-14. doi: 10.1093/humrep/deu265. Epub 2014 Oct 21.
•   Zivi E, Simon A, Laufer N
  Ovarian hyperstimulation syndrome: definition, incidence, and classification. Semin Reprod Med. 2010 Nov;28(6):441-7. doi: 10.1055/s-0030-1265669. Epub 2010 Nov 16. Review.

A Randomized Controlled Trial of Pre-retrieval Triggering Methods in in Vitro Fertilization Patients Classified as Low, Normal or High Responder

Details for clinical trial NCT02715336